Dementia experts hail “watershed moment” after trial results for donanemab antibody treatment.

  • Regna@lemmy.world
    link
    fedilink
    English
    arrow-up
    1
    ·
    1 year ago

    Considering that it is stated that it helped in earlier stages (before they took the patients off donanemab), I don’t think they got as far as claiming it halted the progress. From the article I mainly had the impression that it slowed it enough in some patients to show some progress in the research. Still, this is hopeful, considering the other options that have been available thus far.

    • partial_accumen@lemmy.world
      link
      fedilink
      English
      arrow-up
      2
      ·
      1 year ago

      That was my conclusion from the article too, but where I’m interested in is if the amyloid build up causes permanent damage to the brain, causing dementia, or with the removal of amyloid (which was never possible before) does the patient gain back anything they lost?

      It seems surprising they left that answer out as it is very compelling to how the disease actually works.